Palumbo Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.09M Sell
20,038
-257
-1% -$59.9K 1.07% 25
2026
Q1
$4.96M Buy
20,295
+959
+5% +$223K 1.21% 22
2025
Q4
$4M Buy
19,336
+401
+2% +$79.3K 0.99% 25
2025
Q3
$3.35M Buy
18,935
+682
+4% +$117K 1.07% 25
2025
Q2
$2.79M Buy
18,253
+524
+3% +$80.5K 0.86% 30
2025
Q1
$2.94M Buy
17,729
+5,059
+40% +$792K 0.98% 29
2024
Q4
$1.83M Sell
12,670
-2,845
-18% -$441K 0.68% 38
2024
Q3
$2.51M Sell
15,515
-665
-4% -$106K 0.98% 28
2024
Q2
$2.36M Buy
16,180
+3,050
+23% +$454K 1% 26
2024
Q1
$2.08M Buy
13,130
+3,227
+33% +$514K 0.93% 30
2023
Q4
$1.55M Buy
9,903
+881
+10% +$135K 0.79% 31
2023
Q3
$1.41M Buy
9,022
+3,177
+54% +$524K 0.77% 30
2023
Q2
$968K Buy
+5,845
New +$943K 0.59% 34

Other funds holding JNJ

Palumbo Wealth Management's JNJ Position: Q2 2026 in Review

Palumbo Wealth Management reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q2 2026, selling an estimated $59.9K and leaving 20,038 shares worth $5.09M. The position accounts for 1.07% of the portfolio, ranked #25.

Palumbo Wealth Management first reported a position in JNJ in Q2 2023 and has held it in 13 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Palumbo Wealth Management held 20,038 shares of Johnson & Johnson worth $5.09M as of Q2 2026.
  • Palumbo Wealth Management sold 257 Johnson & Johnson shares in Q2 2026, an estimated $59.9K.
  • Johnson & Johnson made up 1.07% of Palumbo Wealth Management's portfolio in Q2 2026, its #25 holding.
  • Palumbo Wealth Management first reported a position in Johnson & Johnson in Q2 2023 and has held it in 13 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.